medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2009, Number 1

<< Back Next >>

Arch Neurocien 2009; 14 (1)

Funtional sequences in magnetic resonance

Contreras LOA

Language: Spanish
References: 54
Page: 58-68
PDF size: 303.55 Kb.


ABSTRACT

The functional sequence of RM ( IDW, DTI, SRM and PRM), are powerful tools, wich to add conventional resonance magnetic result larger capacity diagnostic, ennoble the sensitivity and specificity for each patologic entity. The knowledge of principies physical for each type sequences, as soon as artifact that change image qulity and pos-process, are elements that know the radiologist for appropriate interpretation. Since end the last century, to added more an more knowledge to resonance magnetic, this work is review of literature and treat above the principies physical, the artifact that disturbance image and to explain the intensity signal changes from phisyopatologic point and indications.


REFERENCES

  1. Gili J, Alonso J. Introducción biofísica a la resonancia magnética en neuroimagen. 1a. Edición. Técnicas especiales en RM. Barcelona, 2000:1- 34.

  2. RB Buxton, LR Frank, PV Prasad. Principes of difusión and Perfusion MRI. Clinical magnetic resonance imaging. Saunders, 1990;vol.8:233.

  3. Melhem ER, Mori S, Mukunda G, Kraut MA, Pomper MG, Van Zijl PCM. Diffusion tensor MR imaging of the brain and white matter tractography. AJR 2002;178:3-16

  4. Tun GA, Rogg JM. Diffusion weighted imaging of cerebritis. AJNR 2003;24:1110-3.

  5. Beauchamp NJ. Diffusion Imaging in Stroke: Review and Controversies. Radiographics 1998;18:1269-83.

  6. Douek P, Tunner R, Pekar J, Patronas N, Le Bihan D. MR color mapping of myelin fiber orientation. J Comput Assist Tomogr 1991;15:923-9.

  7. Mori S, Crain BJ, Chacko VP, van Zijl PCM. Trhee-dimensional tracking of axonal projections in the brain by megnetic resonance imaging. Ann Neurol 1999;45:265-9.

  8. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn Reson Med 2000;44:632-52.

  9. Conturo TE, Lori NF, Cull TS. Tracking neuronal fiber Pathways in the living human brain. Proc Natl Acad USA 1999;96:10422-7.

  10. Cleveland GC, Chang DC, Hazelwood CF. Nuclear magnetic resonance measurements of skeletal mustie: anisotropy of the diffusion coefficient of the intracellular water. Biophys J 1976;16:104-5.

  11. Lutsep HL, Albers GW, De Crespigny A, Kamat GN, Marks MP, Moseley ME. Clinical utility of difusion-weight magneticresonance imaging in the assesment of ischemic stroke. Ann Neurol 1997;41:574-80.

  12. Hsu EW, Muzikant AL, Matulevicius SA, Penland RC, Henriquez CS. Magnetic resonante myocardial fiber-orientation mapping with direct histological correlation. Am J Pysiol 1998;274:H1627- H34.

  13. TG Reese, RM Weisskoff, RN Smith, BR Rosen, RE Dinsmore, VJ Wedeen. Imaging myocardial fiber architecture in vivo with magnetic resonance. Magn Reson Med 1995;4:786-91

  14. Hsu EW, Setton LA. Diffusion tensor microscopy of intervertebral disc annulus fibrosus. Magn Reson Med 1999;41:992-9.

  15. PeledS, Gudbjarstsson H, Westin CF, Kikinis R, Jolesz FA. Magnetic resonance imaging showing orientation and asymmetry of white matter fiber tracts. Brain Res 1998;8:87-96.

  16. Moseley ME, Butts K, Yenari MA, Marks M, de Crespigny A. Clinical aspects of DWI. NMR Biomed 1995;8:87-96

  17. 17.Warach S, Gaa J, Siewert B, Weilpolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion weight magnetic resonance imaging. Am Neurol 1995;7:231-41.

  18. Neil JJ, Shiran SI, Mc Kinistry RC. Normal brain in human newborns: apparent diffusion and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 1998;209:57-66.

  19. Huppi PS, Maiser SE, Peled S. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res 1998;44:584-90.

  20. Guo AC, Petrella JR, Kutzberg J, Provenzale JM. Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology 2001;218:809-15.

  21. Ito R, Melhem ER, Mori S, Eicher FS, Raymond GV, Moser HW. Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy. Neurology 2001;56:544-7.

  22. Pomara N, Crandll DT, Choi SJ, Johnson G, Lim KO. White matter abnormalities in HIV-1 infection: diffusion tensor imaging study. Psychiatry Res 2001;106:15-24

  23. Bammer R, Augustin M, Strasser-Fuch S. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn ResonMed 2000;44:583-91.

  24. Ciccarelli O, Werning DJ, Wheeler-Kingshott CA. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;(56)926-33.

  25. Filippi M, Cercignani M, Horsfield MA, Comi G. Diffusion Tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304-11.

  26. Schwartz RB, Mulken RV, Gudbjartsson H, Jolesz F. Diffusionweight MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR 1998;19:859-62.

  27. Sullivan EV, Adalsteinsson E, Hedehus M. Equivalent disruption of regional white matter microstructure in aginig healthy men and women. Neurologyreport 2001;12:99-104.

  28. Rose SE, Chen F, Chalk JB. Loss of connectivity in Alzheimer’s disease: an evaluation of white matter tract integrity with colorcoded MR diffusion tensor imaging. J Neurol NeurosurgPysichiatry 2000;69:528-30.

  29. J Foong, M Maier, CA Clark, GJ Barker, DH Miller, MA Ron. Neuropathological abnormalities of the corpus callosum inschizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Pysichiatry 2000;68:242-4.

  30. Jones DK, Lythgoe D, Horsfiel MA, Simmons A, Williams SC, Markus HS. Characterization of white matter damage in schemic leukoaraiosis with diffusion tensor MRI. Stroke 1990;30:393-7.

  31. Eriksson SH, Rugg Gunn FJ, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain 2001; 124:627- 36.

  32. Krabbe K, Gideon P, Wagn P. Diffusion imaging of human intracranial tumors. Neurorradiology 1997;39:483-9.

  33. Chabriat H, Vahedi K, Clark CA. Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene. Neurology 2000;54:510-2.

  34. Schaefer PW, Buonanno FS, González RG, Schwamm LH. Diffusion-weighted imaging discriminates beteween cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28:1082-5.

  35. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288-92.

  36. Danielsen ER, Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York:Marcel Dekker 1999:5-22.

  37. Cousing JP. Clinical MR spectroscopy. Fundamentals, current applications and future potentials. AJR 1995;164:1337-47.

  38. Kohler S. Single voxel proton brain exam. Applications guide Sima advantage. General Electric Company, 1993.

  39. Castillo M, Kwock J, Scatiff J. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Neuroimaging Clin North Am 1998;6:1-19.

  40. Van der Knapp MS, Valk J. Magnetic resonance of myelin, myelination and myelin disorders, 2nd. ed. NewYork: Springer, 1995.

  41. Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: assessement with proton MR spectrscopy. AJNR 2001;22:128-35.

  42. Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 1999;56:919-26.

  43. Burstcher 1M, Stahlberg F, Holtas S. Proton (1H) MR spectroscopy for routine dignostic evaluation of brain lesions. Acta Radiologica 1997;38:953-60.

  44. Ishimaru H, Nakashima K, Morikawa M. Improved diagnostic accuracy of contrast enhancing brain lesions with recently developed MR techniques: diffusion-weight image, perfusion image and MR spectroscopy. Presented at the 39th Annual Meeting of the American Society of Neurorradiology, Boston, April 2001.

  45. Danielsen ER, Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York:Marcel Dekker 1999:1-43.

  46. Salibi N, Brown M. Clinical MR spectroscopy- first principles-. New York: Wiley-Liss, 1998:62-99, 143-64.

  47. Smith JK, KwockL, Castillo M. Effects of contrast material on single volume proton MR spectroscopy. AJNR 2000;21:1084-9.

  48. Kimura H, Fujii Y, Itoh S. Metabolic alterations in the neonato and infant brain during development: evaluation with proton MR spectroscopy. Radiology 1995;194:483-9.

  49. Byrd Se, Tomita T, Palka Ps. Magnetic resonance spectroscopy in the evaluation of pediatric brain tumors. Part 1: Introduction to ERM. J Natl Med Assoc 1996;88:649-54.

  50. Aragao F, Mourao M, Mendonca R,. Neuroespectroscopy- a pictorial essay and review of how to obtain and interprete MR spectroscopy. Presented at the 39 th annual meeting of the American Society of Neurorradiology, Boston, April 2001.

  51. Haely MP, McKnight T, Priest D, et al. MR spectroscopy analysis of metabolities in different regions of normal brain. Presented at the 39th Annual meeting of the American Society of Neurorradiology, Boston, April 2001.

  52. Caldwelw J, Kanamalla U, Baker K. Proton spectroscopy findings of periventricular subcortical white matter (terminal zone). Presented at the 39th Annual Meeting of the American Society of Neurorradiology, Boston, April 2001.

  53. Lam WW, Wang Zj, Zhao Hl. 1HMR spectroscopy of basal ganglio in childhood: a semiquantitative analysis. Neurorradiology 1998;40:315-23.

  54. Brandao LA, Domingues RC. Mr espectrscopy of the brain. Philadelphia: Lippincott Williams and Wilkins, 2004:2-14.




2020     |     www.medigraphic.com